FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC

Cancer statistics, 2018

(2018) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The DUF1669 domain of FAM83 family proteins anchor casein kinase 1 isoforms

(2018) Luke J. Fulcher et al.   Science Signaling

The DUF1669 domain of FAM83 family proteins anchor casein kinase 1 isoforms

(2018) Luke J. Fulcher et al.   Science Signaling

HER2-positive breast cancer cells expressing elevated FAM83A are sensitive to FAM83A loss

(2017) Courtney A. Bartel et al.   PLoS One

FAM83 proteins: Fostering new interactions to drive oncogenic signaling and therapeutic resistance

(2016) Courtney A. Bartel et al.   Oncotarget

Glycodelin: A New Biomarker with Immunomodulatory Functions in Non-Small Cell Lung Cancer

(2015) M. A. Schneider et al.   CLINICAL CANCER RESEARCH

FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma

(2015) NAOYUKI OKABE et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

FAM83B-mediated activation of PI3K/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapies.

(2015) Rocky Cipriano et al.   Oncotarget

The least dense hyperball covering of regular prism tilings in hyperbolic $$n$$ n -space

(2014) Jenő Szirmai   ANNALI DI MATEMATICA PURA ED APPLICATA

Drug resistance to targeted therapies: Déjà vu all over again

(2014) Floris H. Groenendijk et al.   Molecular Oncology

AZD9291, an Irreversible EGFR TKI, Overcomes T790M-Mediated Resistance to EGFR Inhibitors in Lung Cancer

(2014) D. A. E. Cross et al.   Cancer Discovery

Novel therapeutic targets in non-small cell lung cancer

(2013) Muhammad Alamgeer et al.   CURRENT OPINION IN PHARMACOLOGY

FAM83A confers EGFR-TKI resistance in breast cancer cells and in mice

(2012) Sun-Young Lee et al.   JOURNAL OF CLINICAL INVESTIGATION

FAM83A and FAM83B: candidate oncogenes and TKI resistance mediators

(2012) Steven Grant   JOURNAL OF CLINICAL INVESTIGATION

FAM83B mediates EGFR- and RAS-driven oncogenic transformation

(2012) Rocky Cipriano et al.   JOURNAL OF CLINICAL INVESTIGATION

Quantitative Proteomics with siRNA Screening Identifies Novel Mechanisms of Trastuzumab Resistance in HER2 Amplified Breast Cancers

(2012) Alaina P. Boyer et al.   MOLECULAR & CELLULAR PROTEOMICS

Establishment and comparative characterization of novel squamous cell non-small cell lung cancer cell lines and their corresponding tumor tissue

(2011) Sandra Gottschling et al.   LUNG CANCER

East meets West: ethnic differences in epidemiology and clinical behaviors of lung cancer between East Asians and Caucasians

(2011) Wei Zhou et al.   Chinese Journal of Cancer

TNM-System 2010

(2010) C. Wittekind et al.   Onkologe

The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments

(2009) S. A. Bustin et al.   CLINICAL CHEMISTRY